Hitoshi Matsuda
Director/Board Member at GNI Hong Kong Ltd.
Profile
Hitoshi Matsuda currently works at GNI-EPS Pharmaceuticals, inc., as Director from 2013, GNI Hong Kong Ltd., as Director from 2013, and Shanghai Genomics, Inc., as Auditor from 2013.
Mr. Matsuda also formerly worked at GNI Group Ltd., as Chief Operating Officer & Director and Continent Pharmaceutical Inc., as Director.
Mr. Matsuda received his graduate degree from Keio University.
Hitoshi Matsuda active positions
| Companies | Position | Start |
|---|---|---|
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Comptroller/Controller/Auditor | 01/07/2013 |
| GNI-EPS Pharmaceuticals, inc. | Director/Board Member | 01/07/2013 |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Director/Board Member | 01/07/2013 |
Former positions of Hitoshi Matsuda
| Companies | Position | End |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Director/Board Member | - |
| GNI GROUP LTD. | Chief Operating Officer | - |
Training of Hitoshi Matsuda
| Keio University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GNI GROUP LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
| GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Commercial Services |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Hitoshi Matsuda
